CAMERON ALLEN: Open Payments
NPI 1972122844 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 10 payments from 8 companies in 2025. Trend: 2023 $67 · 2024 $214 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| HISTOSONICS, INC. | 1 | $97 |
| Janssen Biotech, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, IQIRVO, OMVOH, VELSIPITY.
Industry payments across AZ — which companies pay providers there.
